A Registry of Cardiac PET and CardioFlux Magnetocardiography in Patients with Suspected Coronary Ischemia.
Recruiting
- Conditions
- Coronary; Ischemic
- Registration Number
- NCT05868902
- Lead Sponsor
- Genetesis Inc.
- Brief Summary
A multicenter observational data development registry collecting diagnostic measures via standard of care (SOC) cardiac PET in order gain a better understanding of how CardioFlux MCG may be used in the detection of coronary ischemia.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
- Willing to provide informed consent
- Male or female, aged 40 and up (inclusive) at the time of enrollment
- Clinical suspicion of myocardial ischemia that clinician desired cardiac PET
- Completed cardiac PET within 2 weeks prior to study enrollment
Exclusion Criteria
- Patients unable to fit into CardioFlux device.
- Patients unable to lie supine for 5 minutes.
- Patients with implanted ferromagnetic objects above the costal margin of the rib cage (implanted pacemakers, cardioverter/defibrillators, infusion pumps, and/or neuro stimulators). NOTE: Sternotomy wires stents are acceptable
- Ongoing atrial fibrillation or atrial flutter
- Life expectancy <1 yrs. due to non-cardiovascular comorbidity
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To collect diagnostic data using SOC diagnostic cardiac PET testing for the purposes of gaining a better understanding of how CardioFlux MCG may be used in the detection of coronary ischemia 24 months
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie CardioFlux MCG's detection of coronary ischemia compared to cardiac PET?
How does CardioFlux Magnetocardiography compare to standard-of-care cardiac PET in detecting ischemic heart disease?
Which biomarkers correlate with CardioFlux MCG diagnostic accuracy in patients with suspected coronary ischemia?
What adverse events are associated with CardioFlux MCG versus cardiac PET in coronary diagnostics?
Are there combination approaches involving CardioFlux MCG and other devices for coronary ischemia detection?
Trial Locations
- Locations (2)
Cleveland Clinic
🇺🇸Cleveland, Ohio, United States
Kettering Health
🇺🇸Kettering, Ohio, United States
Cleveland Clinic🇺🇸Cleveland, Ohio, United StatesCynthia RosserContact(216) 444-4372rosserc@ccf.orgWael Jaber, MDContact